Acadian Asset Management LLC Tempest Therapeutics, Inc. Call Options Transaction History
Acadian Asset Management LLC
- $34.5 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
38Shares Held
5.53MCall Options Held
44.9KPut Options Held
109K-
Versant Venture Management, LLC San Francisco, CA3.51MShares$3.26 Million4.35% of portfolio
-
Black Rock Inc. New York, NY550KShares$511,7240.0% of portfolio
-
Geode Capital Management, LLC Boston, MA354KShares$329,4760.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$163,8590.0% of portfolio
-
Xtx Topco LTD London, X0161KShares$149,5500.01% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $9.69M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...